abrdn Life Sciences Investors
HQL- Exchange
- NYSE
- SEC CIK
- 0000884121
No open-market purchases or sales by abrdn Life Sciences Investors insiders were filed in the last 90 days; 86 institutions reported holding it in 13F filings for Q2 2026, worth $156.8M in total; no superinvestor holds it.
- Source
- SEC XBRL data (10-K, 10-Q, 20-F, 40-F)
No financial statements
abrdn Life Sciences Investors has no financial statements on Livermore. They come from the XBRL data in 10-K, 10-Q, 20-F and 40-F filings, so ETFs, funds and companies that don't file these reports have none.